The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1366
June 13, 2011
View Complete Issue         Table of Contents 2019 
Aromatase Inhibitors for Adjuvant Treatment of Postmenopausal Breast Cancer
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Aromatase Inhibitors for Adjuvant Treatment of Postmenopausal Breast Cancer
June 13, 2011 (Issue: 1366)
Adjuvant hormone therapy with anti-estrogen drugs has been shown to reduce disease recurrence and mortality in postmenopausal women with estrogen receptor (ER)-positive breast cancer. In recent years, aromatase inhibitors (AI) have become the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Aromatase Inhibitors for Adjuvant Treatment of Postmenopausal Breast Cancer
Article code: 1366c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.